While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

But have you ever wondered who holds the acclaim of top spot for the most subscribed channel? Wonder no more, here are the 10 YouTube channels with the most subscribers, according to Social Blade.

See the top shows on Netflix and learn about the Netflix Top 10 with our list of the most popular series right now on the platform, plus reviews, updated weekly.

Shares of Hikma Pharmaceuticals PLC HIK slid 1.18% to £20.04 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.20% to 9,120.31 ...

Hikma Pharmaceuticals PLC closed 14.07% short of its 52-week high of £23.60, which the company reached on February 13th.

So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are ...

The expansion will grow domestic capacity across four sites and support the production of more than 12 billion doses of ...

The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV) rose nearly 4% in the week, outpacing the broader markets. On a ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

Cipla , India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs.

Sarepta faces an “arduous and treacherous path” to try to get its Duchenne muscular dystrophy therapy Elevidys back onto the ...

The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...